Correction to Synthesis of Potent and Selective Inhibitors of Aldo-Keto

Addition/Correction Cite This: J. Med. Chem. 2018, 61, 1380−1380

pubs.acs.org/jmc

Correction to Synthesis of Potent and Selective Inhibitors of AldoKeto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells Satoshi Endo,* Shuang Xia, Miho Suyama, Yoshifumi Morikawa, Hiroaki Oguri, Dawei Hu, Yoshinori Ao, Satoyuki Takahara, Yoshikazu Horino, Yoshihiro Hayakawa, Yurie Watanabe, Hiroaki Gouda, Akira Hara, Kazuo Kuwata, Naoki Toyooka,* Toshiyuki Matsunaga, and Akira Ikari Journal of Medicinal Chemistry 2017, 60, 8441−8455. DOI: 10.1021/acs.jmedchem.7b00830 Page 8451. In Experimenal Section, left column, lines 5−8 from the bottom, the 1H NMR data for 7-hydroxy-2-oxo-2Hchromene-3-carboxylic acid [3-(4-fluorophenyl)propyl]amide (4e) should be changed to the following: 1H NMR (400 MHz, DMSO-d6) δ 1.80 (2H, quint, J = 6.9 Hz), 2.60 (2H, t, J = 6.9 Hz), 3.29 (2H, q, J = 6.9 Hz), 6.79 (1H, d, J = 2.2 Hz), 6.86 (1H, dd, J = 8.8 Hz, 2.2 Hz), 7.08 (2H, t, J = 8.7 Hz), 7.24 (2H, dd, J = 8.7 Hz, 5.5 Hz), 7.80 (1H, d, J = 8.8 Hz), 8.65 (1H, t, J = 6.9 Hz), 8.75 (1H, s), 11.04 (1H, br).

Published: January 11, 2018 © 2018 American Chemical Society

1380

DOI: 10.1021/acs.jmedchem.7b01911 J. Med. Chem. 2018, 61, 1380−1380